3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
2
Thyroid Cancer, Papillary
1
Solid Cancers
1
Lymphoma, Follicular
1
Diabetes Mellitus, Type 2
1
Carcinoma, Renal Cell
1
Alzheimer Disease
1
Adenocarcinoma, Follicular
1
Interventions
relacorilant
5
somapacitan
1
semaglutide
1
saxagliptin
1
pembrolizumab
1
empagliflozin
1
dapagliflozin
1
Rosiglitazone
1
Metformin
1
Dipeptidyl-Peptidase IV Inhibitors
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Diabetes Mellitus, Type 2
×
Rosiglitazone
×
Clear all
NCT01195259
2013-10-28
Malignancy Meta Analysis for BRL49653
GlaxoSmithKline
Completed
1 enrolled